# John Cooke

Nangungunang mga yugto ng podcast
Nai-update:

Local reaction in Waterford after fatal fire

Report from John Cooke See omnystudio.com/listener for privacy information.

Strikes shut down the country

Our reporters have been out and about since early this morning speaking to those on the picket lines. Brian O’Connell, outside St Killians Special School in Mayfield, Cork, Reporter, Una Kelly outside a school in Harold Cross in Dublin and Reporter, John Cooke outside Galway University Hospital.  …

Public sector strikes take place across country

Reports from Brian O'Connell in Cork; John Cooke in Galway; and Una Kelly in Dublin See omnystudio.com/listener for privacy information.

Mourners gather in Waterford for victims of arson attack

Report from John Cooke See omnystudio.com/listener for privacy information.

Calls for reform of Cost of Disability payment

Report from John Cooke See omnystudio.com/listener for privacy information.

The murder of Emer O'Loughlin

Reporter John Cooke joins Fran to discuss the ongoing murder investigation into Co Clare woman, Emer O'Loughlin. Earlier today, a jury at an inquest returned a verdict of unlawful killing. Emer was killed on April 8th 2005 in what were deemed to be suspicious circumstances at the time. Fran and Joh…

Proof of Concept: The Money Is Back In RNA, But What Stands Between Headlines And Routine Medicine?

"The money is back in RNA. In recent weeks, Merck KGaA agreed to pay about $1.1 billion for Silence Therapeutics, Novartis signed a deal worth up to $7.8 billion with Abogen Biosciences, and Roche paid more than $1 billion for an RNAi obesity drug from Rona Therapeutics. Meanwhile, Merck and Modern…

Proof of Concept: The Money Is Back In RNA, But What Stands Between Headlines And Routine Medicine?

"The money is back in RNA. In recent weeks, Merck KGaA agreed to pay about $1.1 billion for Silence Therapeutics, Novartis signed a deal worth up to $7.8 billion with Abogen Biosciences, and Roche paid more than $1 billion for an RNAi obesity drug from Rona Therapeutics. Meanwhile, Merck and Modern…

Proof of Concept: The Money Is Back In RNA, But What Stands Between Headlines And Routine Medicine?

"The money is back in RNA. In recent weeks, Merck KGaA agreed to pay about $1.1 billion for Silence Therapeutics, Novartis signed a deal worth up to $7.8 billion with Abogen Biosciences, and Roche paid more than $1 billion for an RNAi obesity drug from Rona Therapeutics. Meanwhile, Merck and Modern…

Shannon suicide prevention

John Cooke, Reporter See omnystudio.com/listener for privacy information.